Research Articles
Seeing the Invisible: How Targeted Nanotechnology Illuminates Hidden Breast Cancer Cells
Exploring how anti-HER2 immunoliposomes deliver EPR imaging probes to detect HER2-positive breast cancer micrometastases with unprecedented precision.
Taming the Torrent: Mastering Neratinib-Induced Diarrhea in Breast Cancer Care
Comprehensive guide to managing neratinib-induced diarrhea in HER2-positive breast cancer patients, including evidence-based strategies from the CONTROL trial.
The Fungal Warrior: How a Rare Mushroom Compound Is Revolutionizing Breast Cancer Research
Discover how camphorataimide B from Antrodia camphorata shows remarkable potential in fighting triple-negative breast cancer through multiple mechanisms.
The Peach Paradox: How Red Flesh Peaches Wage War on Breast Cancer
Discover how phenolic acids in red flesh peaches selectively target and destroy breast cancer cells through molecular mechanisms.
The HER2 Revolution: How a New Monoclonal Antibody is Redefining Breast Cancer Treatment
Breakthrough in breast cancer treatment with FDA approval of fam-trastuzumab deruxtecan-nxki (Enhertu) for HER2-low and HER2-ultralow metastatic breast cancer.
The PKC Paradox: How a Cellular "Switch" Helps Breast Cancer Cells Survive and Resist Treatment
Exploring how Protein Kinase C (PKC) isoforms, particularly PKCδ, act as prosurvival factors in breast cancer cells and their implications for targeted therapy.
The A3AR Breakthrough: How a Tiny Receptor Could Revolutionize Breast Cancer Treatment
Discover how targeting the A3 adenosine receptor (A3AR) with agonists like Cl-IB-MECA can inhibit breast cancer stem cells (BCSCs) and potentially transform breast cancer treatment.
The Hidden Driver of Aggressive Breast Cancer in Young Women: Unraveling the CXCL13 Mystery
Discover how CXCL13 chemokine drives aggressive breast cancer in young women and the promising therapeutic strategies emerging from recent research.
The Trojan Horse Nano-Warrior: How Retracted Research Advanced HER2+ Breast Cancer Treatment
How a retracted nanoparticle study advanced HER2+ breast cancer treatment through targeted drug delivery concepts
The Double Strike: Unraveling the Second Hit in BRCA-Associated Breast Cancer
Exploring the critical second genetic event that transforms BRCA susceptibility into breast cancer malignancy, with insights into mechanisms, clinical implications, and future research directions.